Anti-decomposition agent for oxidative metabolite of bilirubin
An anti-decomposition and bilirubin technology is applied in the field of anti-decomposition agents for bilirubin oxidative metabolites, which can solve the problems of difficulty in transportation and storage, inability to measure accurate concentrations, and rapid decomposition of bilirubin oxidative metabolites, etc. The effect of preventing decomposition
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0135] (Example 1: Research on anti-decomposition agent of bilirubin oxidative metabolites)
[0136] Antioxidant substances were added to urine to investigate whether the decomposition of oxidized metabolites of bilirubin in urine was inhibited. As antioxidant substances, ascorbic acid (Fujifilm Wako Pure Chemical Industries, Ltd.), sodium chloride (Fujifilm Wako Pure Chemical Industries, Ltd.), reduced glutathione (NACALAI TESQUE, Inc.), L-cysteine ( Fujifilm Wako Pure Chemical Industries, Ltd.), riboflavin (Fujifilm Wako Pure Chemical Industries, Ltd.), and peroxidase (Fujifilm Wako Pure Chemical Industries, Ltd.).
[0137] Urine was collected from humans (N=4), and antioxidant substances were added and incubated at 27°C for 48 hours. Then, the concentration of bilirubin oxidation metabolites in each sample was measured. As a standard sample, a sample stored at -80° C. without adding an antioxidant substance to urine collected from a human was prepared. The concentratio...
Embodiment 2
[0142] (Example 2: Time-dependent changes in the concentration of oxidized metabolites of bilirubin in urine under a severe temperature environment)
[0143] This experiment investigated whether the anti-decomposition agent of the present invention can inhibit the decomposition of bilirubin oxidative metabolites in urine even in a severe temperature environment (about 28°C to about 32°C) in midsummer.
[0144] Urine was collected from 3 healthy persons (2 males and 1 female), and the urine samples were preserved for 5 days under the following conditions (1) to (3). As a standard sample, a sample stored at -80° C. without adding an antioxidant substance to urine collected from a human was prepared. The concentration of bilirubin oxidation metabolites in each urine sample was measured at 24 hours, 48 hours, 72 hours, 96 hours and 120 hours after the start of the experiment. This measurement was performed using a bilirubin oxidation metabolite ELISA kit (Metallogenic).
[014...
Embodiment 3
[0153] (Example 3: Time-dependent changes in oxidized metabolites of bilirubin in urine under low temperature conditions)
[0154] This experiment investigated to what extent the anti-decomposition agent of the present invention can inhibit the decomposition of bilirubin oxidative metabolites in urine under low temperature conditions (about 4°C).
[0155]The same urine sample as in Example 2 was used. Ascorbic acid was added (final concentration 10 mM) and stored at 4°C. The concentrations of bilirubin oxidative metabolites in the urine samples were measured at 24 hours, 48 hours, 72 hours, 96 hours and 120 hours after the start of the experiment. This measurement was carried out using a bilirubin oxidation metabolite ELISA kit (Metallogenic).
[0156] The results are shown in Table 3 and figure 2 . The concentration of oxidized metabolites of bilirubin did not change at all when stored at -80°C. This result shows that when 10 mM ascorbic acid is used and stored at 4° ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


